FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology. Disclosed are compounds, compositions and methods for researching, diagnosing and treating symptoms, diseases and conditions responsive to modulation of expression and/or activity of HBV genes and/or modulation of expression of the HBV gene pathway. Disclosed are double-stranded nucleic acid molecules such as small interfering nucleic acid (siNA), small interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (mRNA), and short hairpin RNA (shRNA) mediating RNA interference (RNAi) against HBV gene expression.
EFFECT: invention expands a range of means for gene therapy.
17 cl, 11 tbl, 6 ex, 10 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS FOR INHIBITION OF PROTEOLYTIC PATH OF ARGININE/N-DEGRON | 2020 |
|
RU2787841C2 |
| MIRNA STRUCTURES WITH HIGH ACTIVITY AND REDUCED EXPOSURE OUTSIDE THE TARGET | 2016 |
|
RU2788030C2 |
| DETERMINATION OF NUCLEIC ACIDS BY AMPLIFICATION BASED ON INCORPORATION INTO CHAIN | 2014 |
|
RU2694976C1 |
| MIR-29 MIMETICS AND WAYS OF USE THEREOF | 2015 |
|
RU2712511C2 |
| NUCLEIC ACID, PHARMACEUTICAL COMPOSITION AND CONJUGATE, METHOD OF PRODUCTION AND USE | 2020 |
|
RU2816898C2 |
| NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF LPA IN CELL | 2018 |
|
RU2822093C1 |
| NUCLEIC ACIDS FOR INHIBITION OF TARGET GENE EXPRESSION CONTAINING PHOSPHODITHIOATE BONDS | 2018 |
|
RU2812806C2 |
| BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING | 2019 |
|
RU2819149C2 |
| METHOD FOR INCREASING THE EXPRESSION OF ENCODED RNA PROTEINS | 2014 |
|
RU2733424C2 |
| METHODS FOR TREATMENT OF HEPATITIS B INFECTION | 2018 |
|
RU2780021C2 |
